ID   MAFG_RAT                Reviewed;         189 AA.
AC   Q76MX4; Q99N83;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 2.
DT   07-APR-2021, entry version 139.
DE   RecName: Full=Transcription factor MafG;
DE   AltName: Full=V-maf musculoaponeurotic fibrosarcoma oncogene homolog G;
GN   Name=Mafg;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INDUCTION, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=CNS;
RX   PubMed=10724342; DOI=10.1023/a:1007017902194;
RA   Shimokawa N., Okada J., Miura M.;
RT   "Cloning of MafG homologue from the rat brain by differential display and
RT   its expression after hypercapnic stimulation.";
RL   Mol. Cell. Biochem. 203:135-141(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INDUCTION, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=11583919; DOI=10.1016/s0898-6568(01)00213-3;
RA   Shimokawa N., Kumaki I., Takayama K.;
RT   "MafG-2 is a novel Maf protein that is expressed by stimulation of
RT   extracellular H(+).";
RL   Cell. Signal. 13:835-839(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Since they lack a putative transactivation domain, the small
CC       Mafs behave as transcriptional repressors when they dimerize among
CC       themselves (By similarity). However, they seem to serve as
CC       transcriptional activators by dimerizing with other (usually larger)
CC       basic-zipper proteins, such as NFE2, NFE2L1 and NFE2L2, and recruiting
CC       them to specific DNA-binding sites (By similarity). Small Maf proteins
CC       heterodimerize with Fos and may act as competitive repressors of the
CC       NFE2L2 transcription factor (By similarity). Transcription factor,
CC       component of erythroid-specific transcription factor NFE2L2 (By
CC       similarity). Activates globin gene expression when associated with
CC       NFE2L2 (By similarity). May be involved in signal transduction of
CC       extracellular H(+) (PubMed:11583919). {ECO:0000250|UniProtKB:O15525,
CC       ECO:0000269|PubMed:11583919}.
CC   -!- SUBUNIT: Homodimer or heterodimer. Homodimerization leads to
CC       transcriptional repression. Forms high affinity heterodimers with
CC       members of the CNC-bZIP family such as NFE2, NFE2L1/NRF1, NFE2L2/NRF2
CC       and NFE2L3/NRF3. Interacts with CREBBP; the interaction leads to
CC       acetylation of the basic region of MAFG and stimulation of NFE2
CC       transcriptional activity through increased DNA binding.
CC       {ECO:0000250|UniProtKB:O15525}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O15525,
CC       ECO:0000255|PROSITE-ProRule:PRU00978}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=MafG2;
CC         IsoId=Q76MX4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q76MX4-2; Sequence=VSP_036798;
CC   -!- TISSUE SPECIFICITY: High expression in the ventral medulla surface
CC       (VMS), heart and skeletal muscle. Lower expression in the cerebral
CC       cortex, cerebellum, liver, stomach and intestine.
CC       {ECO:0000269|PubMed:10724342}.
CC   -!- INDUCTION: Increased levels in the VMS after hypercapnic stimulation.
CC       {ECO:0000269|PubMed:10724342, ECO:0000269|PubMed:11583919}.
CC   -!- PTM: Acetylated in erythroid cells by CREB-binding protein (CBP).
CC       Acetylation augments the DNA-binding activity of NFE2, but has no
CC       effect on binding NFE2. {ECO:0000250|UniProtKB:O15525}.
CC   -!- PTM: Sumoylation at Lys-41 is required for active transcriptional
CC       repression. {ECO:0000250|UniProtKB:O54790}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to intron retention.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the bZIP family. Maf subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB026487; BAA85331.1; -; mRNA.
DR   EMBL; AB050011; BAB41097.1; -; mRNA.
DR   EMBL; CH473948; EDM06874.1; -; Genomic_DNA.
DR   EMBL; CH473948; EDM06875.1; -; Genomic_DNA.
DR   EMBL; CH473948; EDM06876.1; -; Genomic_DNA.
DR   EMBL; BC078828; AAH78828.1; -; mRNA.
DR   RefSeq; NP_071781.1; NM_022386.2. [Q76MX4-2]
DR   RefSeq; XP_006247976.1; XM_006247914.3. [Q76MX4-1]
DR   RefSeq; XP_006247978.1; XM_006247916.3. [Q76MX4-1]
DR   RefSeq; XP_006247980.1; XM_006247918.3. [Q76MX4-1]
DR   RefSeq; XP_006247983.1; XM_006247921.3. [Q76MX4-2]
DR   RefSeq; XP_006247984.1; XM_006247922.3. [Q76MX4-2]
DR   RefSeq; XP_008766704.1; XM_008768482.2. [Q76MX4-2]
DR   RefSeq; XP_017453010.1; XM_017597521.1. [Q76MX4-1]
DR   SMR; Q76MX4; -.
DR   iPTMnet; Q76MX4; -.
DR   PhosphoSitePlus; Q76MX4; -.
DR   Ensembl; ENSRNOT00000054970; ENSRNOP00000051853; ENSRNOG00000036697. [Q76MX4-2]
DR   GeneID; 64188; -.
DR   KEGG; rno:64188; -.
DR   CTD; 4097; -.
DR   RGD; 619953; Mafg.
DR   GeneTree; ENSGT00940000160070; -.
DR   HOGENOM; CLU_112948_0_0_1; -.
DR   InParanoid; Q76MX4; -.
DR   OMA; IREQEHP; -.
DR   OrthoDB; 1395389at2759; -.
DR   PhylomeDB; Q76MX4; -.
DR   TreeFam; TF325689; -.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   PRO; PR:Q76MX4; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Proteomes; UP000234681; Unassembled WGS sequence.
DR   Bgee; ENSRNOG00000036697; Expressed in frontal cortex and 21 other tissues.
DR   Genevisible; Q76MX4; RN.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0030534; P:adult behavior; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0030641; P:regulation of cellular pH; IDA:RGD.
DR   GO; GO:0045604; P:regulation of epidermal cell differentiation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR004826; bZIP_Maf.
DR   InterPro; IPR028551; MafG.
DR   InterPro; IPR008917; TF_DNA-bd_sf.
DR   InterPro; IPR024874; Transcription_factor_Maf_fam.
DR   PANTHER; PTHR10129; PTHR10129; 1.
DR   PANTHER; PTHR10129:SF15; PTHR10129:SF15; 1.
DR   Pfam; PF03131; bZIP_Maf; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF47454; SSF47454; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Alternative splicing; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..189
FT                   /note="Transcription factor MafG"
FT                   /id="PRO_0000368188"
FT   DOMAIN          78..141
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          80..103
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          106..120
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   MOD_RES         87
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   MOD_RES         98
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   MOD_RES         103
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   MOD_RES         151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   CROSSLNK        41
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   CROSSLNK        41
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O15525"
FT   VAR_SEQ         14..40
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10724342,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036798"
SQ   SEQUENCE   189 AA;  20533 MW;  65F5CF89284DC9D4 CRC64;
     MTTPNKGNKA LKVSGEAGLG VCWAGHSYSA LTPCAVPLQV KREPGENGTS LTDEELVTMS
     VRELNQHLRG LSKEEIIQLK QRRRTLKNRG YAASCRVKRV TQKEELEKQK AELQQEVEKL
     ASENASMKLE LDALRSKYEA LQNFARTVAR SPVAPARGPL AAGLGPLVPG KVAATSVITI
     VKSKTDARS
//
